Drug Database
Back to search

Ireland· IE-PA-EU/1/14/979/001-002

Ofev 100 mg Soft capsule

A nintedanib product containing nintedanib, registered in Ireland by Boehringer Ingelheim International GmbH.

ATC L01XE31

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedOfev 100 mg Soft capsuleATCL01XE31REGISTER NO.IE-PA-EU/1/14/979/001…PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nintedanibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

HPRA (Ireland)
Active substance
Nintedanib
Manufacturer
Boehringer Ingelheim International GmbH
Country
Ireland (IE)
ATC code
L01XE31
ATC class
Nintedanib
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/14/979/001-002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for nintedanib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nintedanib against other medicinesHow interaction checks work

Nintedanib · interactions on record

160 records

  • 21 severe
  • 139 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • DexamethasoneH02AB02severe
  • RifampicinJ04AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nintedanib in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nintedanib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Nintedanib Cipla, Nintedanib Ratiopharm
  • Belgium · Nintedanib Accordpharma, Nintedanib Eg
  • Cyprus · Nintedanib Teva
  • Czechia · Nintedanib Glenmark, Nintedanib Sandoz
  • Germany · Nintedanib, Nintedanib 1 A Pharma
  • Denmark · Nintedanib "sandoz", Nintedanib Glenmark
  • Estonia · Agarf, Nintedanib Sandoz
  • Spain · Nintedanib, Nintedanib Accordpharma
  • Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
  • France · Nintedanib Arrow, Nintedanib Biogaran
  • United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
  • Greece · Nifib, Nindraf
  • Croatia · Gevesla, Nintedanib Accordpharma
  • Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
  • Iceland · Agarf, Nintedanib Accord
  • Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
  • Liechtenstein · Nintedanib Accord, Nintedanib Viatris
  • Lithuania · Agarf, Nintedanib Sandoz
  • Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
  • Latvia · Agarf, Nintedanib Sandoz
  • Malta · Nifiden Adalvo, Nintedanib Adalvo
  • Netherlands · Gevesla, Nintedanair
  • Norway · Nintedanib Accord, Nintedanib Devatis
  • Poland · Nintedanib, Nintedanib Accordpharma
  • Portugal · Nintedanib Accordpharma, Nintedanib Eugia
  • Romania · Gevesla, Nintedanib Dr. Reddy’s
  • Sweden · Nintedanib Devatis, Nintedanib Glenmark
  • Slovenia · Nintedanib Accordpharma, Nintedanib Stada
  • Slovakia · Nintedanib Stada, Nintedanib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9aa1211-4cec-4ade-8d52-eebcc1e53a62
GET /v1/drugs/c9aa1211-4cec-4ade-8d52-eebcc1e53a62?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, soft",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XE",
    "L01XE31"
  ],
  "strength": null,
  "pa_number": "EU/1/14/979/001-002",
  "substances": [
    "Nintedanib"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "15/01/2015",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0206-024-001"
}
API referenceMCP serverPlans

See everything about nintedanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console